User:Mr. Ibrahem/Brigatinib

Brigatinib, sold under the brand name Alunbrig among others, is a medication used to treat non-small cell lung cancer (NSCLC). Specifically it is used for metastatic cases that are ALK-positive. It is taken by mouth.

Common side effects include diarrhea, tiredness, nausea, rash, muscle pain, headache, high blood pressure, and shortness of breath. Other side effects may include pneumonitis, vision problems, muscle breakdown, pancreatitis, high blood sugar, and sunburns. Use in pregnancy may harm the baby. It is a tyrosine kinase inhibitor that blocks ALK.

Brigatinib was approved for medical use in the United States in 2017 and Europe in 2018. In the United Kingdom 4 weeks of medication costs the NHS about £4,900 as of 2021. This amount in the United States is about 17,400 USD.